People, people, people. I just spent a hour listening to the conference call. Wow, I had to start taking notes.
First off listen to what he said about BICX101 and how it needs more work. Wow! I thought the product was 100% ready to go for the fda process for approval, now his comment was basically it needs more work?
Then you hear him say most insurance companies won’t cover the implant - Bicx102. I wish I wasnon the conference call I would have asked “Brady name one insurance company that will please, because I don’t think there is any who will pay for an implant.”
Half the conference call was focused on speculating how much money they’d make with the implant. But that’s if it is ever covered by insurance!!! Which brings me back to a point why would insurance companies pay $8,000+ for the implant when they can just pay $40 for the oral pills? It makes no sense. Oh, because implant gives off a continuous medicine feed? Oh wait doesn’t the injectables on the market do the same? Oh my...
Which one of you stated that the FDA gave them direction to move towards he implant? Because he clearly said state and blah blah, never once mentioned FDA. He must be talking about non-profit groups recommending it or state legislators. Definitely not FDA in my opinion.
Thanks for your questions Adam. Let’s look back a second. Bicx is trying to uplist to Nasdaq but CEO doesn’t remember the exact minimum stock price needed? What paperwork did he file, did he just download it on Google? Because I’m just a putz private investor and I know the minimum requirements needed to uplist to Nasdaq, why doesn’t the CEO of a company remember on the spot? Oh and the minimum price needs a consecutive amount of days at that minimum price also FYI.
Then he said banks or financial companies are trying to finance them? Really!? Because it doesn’t seem like that, seems they are going around begging for money and hardly anyone wants to help. Another investor called their financiers loan sharks. High interest rates/repayment options surreal.
Reverse split - I don’t think it’ll happen extremely soon for Nasdaq reasons. But yes they will surely dilute you pretty soon! That might come with a reverse split during/after. In my opinion.
Brady even said they have had the implant for years but then bye gooley why isn’t it fda approved by now? Shucks because they were pumping the injectable but just now we here it wasn’t ever fully ready? Geez petes.
To the guy Nathan who’s using the term buy-out, keep dreaming pal. No company is willing to buy out them in my opinion. They don’t have any product worth buying yet.
Get insurance companies to cover it then it’s worth buying, until then it’s probably consider “comestic”.
Before I heard the conference call I thought the true value of the company was 8 cents. Now after I heard it, I think 2-4 cents a share.
It’ll cost millions to finance fda approval. NIDA, NIDA grant though man, what about them. Well look up how much they pay and the requirements.
90% of you all need to do some more research before saying “I’m going long”. Because this company is merely just a swing trade flip.
Brady and other executives are nice people and especially Brady working hard promoting the company, but I think his objectives are misguided and he’s basically got hopes and dreams, but steering a boat without a map.
$32.8 million market cap - for what? A company with low funds and no product fda approved and hoping to secure funds to have a product approved by end of 2021. If you think this will be approved by January 1st 2020 then my future kids are going to Harvard for free.
Keep dreaming everyone.
Kizer I have respect for you and thanks for your feedback to Nathan, I’m assuming you lowered your position or are considering it a loss. Because he mentioned buyout, you disagreed. Glad we come to an agreement on that because I don’t see it happening at all.
Anyways anyone know when the next tv show appearance is so I can have funds avaible? I see this going down below 8 cents soon.
This is all my opinion and hey I’m a putz investor.
By the way there are hundreds of OTC companies that don’t generate money, they basically live off of the shareholder and finance companies.
AI
